Sunny Health and Pegasus Launch a $3.5 Billion AI-Centric CVC Fund

Sunny Health and Pegasus Ventures Collaborate on a New CVC Fund

In an exciting development for the tech and health sectors, Japan's Sunny Health and the US-based Pegasus Tech Ventures have announced the launch of a $3.5 billion Corporate Venture Capital (CVC) fund centered around generative AI. This partnership signifies a major step in fostering innovative technologies and investment opportunities, particularly in Silicon Valley, where Pegasus has established its roots.

Pegasus Tech Ventures, renowned for its pioneering role in the CVC 4.0 model, is led by CEO Anis Uzzaman. Together with Sunny Health, which operates in diverse sectors such as nutritional supplements, solar energy, and aircraft leasing, they aim to expand their investment strategies significantly. The fund's operational period is set to extend, aligning with their ambitious goals.

The collaboration began in 2015 with an initial fund of approximately ¥2.9 billion. Since then, the fund has undergone multiple expansions to reach its current impressive scale. This latest announcement marks an era of actively pursuing strategic investments, particularly within the rapidly evolving world of AI technology.

To kick off their investment campaign, the newly formed fund has already made significant strides. Notable investments include industry leaders in generative AI, such as OpenAI, Anthropic, and x.AI—the latter founded by renowned entrepreneur Elon Musk. The fund intends to broaden its focus beyond AI, targeting sectors like space tech, healthcare, fintech, and retail.

Masahiro Nishimura, CEO of Sunny Health, expressed pride in this collaboration. He remarked, “Our partnership with Pegasus Tech Ventures began in 2015, allowing us invaluable experiences, including public offerings for companies like Money Forward and AirTrip. After multiple investments in SpaceX, we've witnessed firsthand the vibrancy and growth of Silicon Valley's innovative companies. Through this new fund, we’re excited to invest in global leaders like OpenAI and Anthropic while gaining international perspectives from Japan.”

Meanwhile, Anis Uzzaman, the CEO of Pegasus, reflected on their decade-long partnership, emphasizing the incredible journey they’ve embarked on together. He highlighted that their collaborative investments have yielded an overall growth of +230%, contributing to a well-balanced portfolio globally. “We look forward to pushing for further advancements around the world alongside Sunny Health,” he noted.

About Sunny Health

The Sunny Health Group, through its parent company and several subsidiaries, engages in a wide array of global businesses, from selling micro-diets to solar energy and aircraft leasing. Under the leadership of Masahiro Nishimura since May 2016, the company has embarked on robust investment activities targeting startups in both the US and Japan. For more information, please visit Sunny Health’s website.

About Pegasus Tech Ventures

Pegasus Tech Ventures operates out of Silicon Valley and has received investments from over 40 leading companies worldwide. They have successfully funded over 270 startups primarily in the US, Japan, and Southeast Asia. They have invested in a variety of companies, including publicly listed firms such as Money Forward, Metaps, and AirTrip, and have established a record of supporting their portfolio companies in international expansion and fundraising efforts. More information can be found on their official site.

In addition, Pegasus promotes global innovation by hosting one of the world’s largest networking and pitch contests, the Startup World Cup, which conducts qualifiers in over 100 countries. This contest supports startups in their journey toward recognition and investment on the global stage.

With their joint initiatives, Sunny Health and Pegasus are positioning themselves at the forefront of the AI investment landscape, ready to shape future technological innovations.